Striking complete remission after interferon-α for secondary recurrent non-Hodgkin's lymphoma but rare interferon-induced side effects

Annals of Hematology

Volumn 84, Issue 4, 2005, Pages 263-266

  Deschler, Barbara ^a   Reincke, Martin ^a   Bley, Thorsten A ^a   Brink, Ingo ^a   Engelhardt, Monika ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Interferon treatment; Non Hodgkin'slymphoma; Peripheral blood stem cell transplantation

Indexed keywords

ALPHA INTERFERON; BLEOMYCIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOFOS; MELPHALAN; METHOTREXATE; PREDNISONE; PROCARBAZINE; THYROXINE; VINCRISTINE;

ADULT; AGEUSIA; ANOSMIA; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER RELAPSE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG WITHDRAWAL; FATIGUE; FLU LIKE SYNDROME; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; LICHENOID ERUPTION; LYMPHADENOPATHY; MALE; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; SPLENECTOMY; TREATMENT OUTCOME;

DRUG EVALUATION; HUMANS; INTERFERON-ALPHA; LYMPH NODES; LYMPHOMA, NON-HODGKIN; MALE; NEOPLASMS, SECOND PRIMARY; RECURRENCE; REMISSION INDUCTION;

EID: 15844372253     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-004-0861-z     Document Type: Article

References (14)

1. Antin JH (2002) Long-term care after hematopoietic cell transplantation in adults. N Engl J Med 347:36-42 10.1056/NEJMcp010518
2. Jonasch E, Haluska FG (2001) Interferon in oncological practice: A review of Interferon biology, clinical applications and toxicities. Oncologist 6:34-55 1:CAS:528:DC%2BD3MXhtlKjsbc%3D
3. Marcellin P, Pouteau M, Renard P, et al. (1992) Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C. Gut 33:855-856 1:STN:280:By2A38vms1U%3D
4. Manzano Alonso ML, Munoz Gomez R, Castellano Tortajada G, Solis Herruzo A (2001) IFN-induced anosmia y ageusia in chronic hepatitis C (in Spanish). Gastroenterol Hepatol 24:412
5. Kraus I, Vitezic D (2000) Anosmia induced with alpha interferon in a patient with chronic hepatitis C. Int J Clin Pharmacol Ther 38:360-361 1:STN:280:DC%2BD3M%2Fjs1KlsQ%3D%3D
6. Cocquyt VF, Van Belle SJ (1994) Anosmia associated with alpha-interferon treatment. Ann Oncol 5:863 1:STN:280:ByqC2M7mtFQ%3D
7. Maruyama S, Hirayama C, Kadowaki Y, et al. (1998) Interferon-induced anosmia in a patient with chronic hepatitis C. Am J Gastroenterol 93:122-123 10.1016/S0002-9270(98)80005-1
8. Spaepen K, Stroobants S, Dupont P, Vendenberghe P, Maertens J, Bormans G, Thomas J, Balzarini J, De Wolf-Peters C, Mortelmans L, Verhoef G (2003) Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation. Blood 102:53-59 10.1182/blood-2002-12-3842
9. Hermine O, Lefrere F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, Delmas B, Valensi F, Cacoub P, Brechot C, Varet B, Troussard X (2002) Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 347:89-94 10.1056/NEJMoa013376
10. Allen IE, Ross SD, Borden SP, Monroe MW, Kupelnick B, Connelly JE, Ozer H (2001) Meta-analysis to assess the efficacy of Interferon-α in patients with follicular Non-Hodgkin's Lymphoma. J Immunother 24:58-65 10.1097/00002371-200101000-00007
11. Hagenbeek A, Carde P, Meerwaldt JH, et al. (1998) Maintenance of remission with human recombinant interferon α-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. J Clin Oncol 16:41-47 1:CAS:528:DyaK1cXmtlerug%3D%3D
12. Enschede SH, Shahidi H, Venogopal P, Riley MB, Huang R, Jajeh A, Preisler HD, Gregory SA (2001) Effectiveness of interferon-alfa and mid-cycle chemotherapy added to an anthracycline-based regimen in the treatment of aggressive non-Hodgkin's lymphoma. Leuk Lymphoma 40:325-334 1:CAS:528:DC%2BD3MXjs1Wjt7k%3D
13. Palmieri G, Morabito A, Rea A, Caraglia M, Tagliaferri P, Bianco AR (1994) Cytosine arabinoside (ARA-C) plus alpha-interferon (alpha IFN) determine prolonged complete remissions in patients with aggressive non-Hodgkin's lymphoma particularly responsive to first-line doxorubicin-containing regimens. Br J Haematol 88:421-423 1:STN:280:ByqC3c7lt1c%3D
14. Porrata LF, Inwards DJ, Lacy MQ, Markovic SN (2001) Immunomodulation of early engrafted killer cells with interleukin-2 and interferon-α in autologous stem cell transplantation. Bone Marrow Transplant 28:673-680 10.1038/sj.bmt.1703203